HealthInvest Partners’s Celcuity CELC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.49M Sell
33,313
-107,983
-76% -$12.5M 0.94% 35
2026
Q1
$5.14M Buy
141,296
+99,465
+238% +$10.8M 1.66% 27
2025
Q4
$4.17M Buy
41,831
+4,674
+13% +$384K 1.33% 28
2025
Q3
$195K Buy
+37,157
New +$1.49M 0.72% 36

Other funds holding CELC

HealthInvest Partners's CELC Position: Q2 2026 in Review

HealthInvest Partners reduced its Celcuity (CELC) stake by 76% in Q2 2026, selling an estimated $12.5M and leaving 33,313 shares worth $3.49M. The position accounts for 0.94% of the portfolio, ranked #35.

HealthInvest Partners first reported a position in CELC in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.14M in Q1 2026. 36 funds tracked by Wall St. Rank hold CELC as of Q2 2026.

  • HealthInvest Partners held 33,313 shares of Celcuity worth $3.49M as of Q2 2026.
  • HealthInvest Partners sold 107,983 Celcuity shares in Q2 2026, an estimated $12.5M.
  • Celcuity made up 0.94% of HealthInvest Partners's portfolio in Q2 2026, its #35 holding.
  • HealthInvest Partners first reported a position in Celcuity in Q3 2025 and has held it in 4 quarters since.
  • HealthInvest Partners's Celcuity position peaked at $5.14M in Q1 2026.
  • 36 funds tracked by Wall St. Rank held Celcuity as of Q2 2026.

Based on HealthInvest Partners's 13F filing for Q2 2026, filed 24 Jul 2026.